Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan and Amlodipine in Essential Hypertension
NCT01518998Phase 2Completed
- Sponsor
- Boryung
- Start
- Aug 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fimasartan in essential hypertension, sponsored by Boryung. Started Aug 2011; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01518998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518998.